Pictet Asset Management Holding SA cut its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 482,026 shares of the pharmacy operator's stock after selling 24,140 shares during the period. Pictet Asset Management Holding SA owned approximately 0.06% of Walgreens Boots Alliance worth $4,497,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. First Financial Corp IN lifted its stake in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in Walgreens Boots Alliance during the 4th quarter valued at $26,000. Riverview Trust Co lifted its position in Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after buying an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the fourth quarter worth $28,000. Finally, TD Private Client Wealth LLC boosted its stake in Walgreens Boots Alliance by 8,670.3% during the third quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator's stock worth $29,000 after buying an additional 3,208 shares during the period. 58.59% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on WBA. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and lowered their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Truist Financial decreased their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Bank of America raised their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research note on Monday, January 13th. Wolfe Research raised Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Finally, Evercore ISI lifted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $10.59.
Check Out Our Latest Analysis on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Down 3.4 %
Walgreens Boots Alliance stock traded down $0.38 during trading hours on Friday, reaching $10.68. The stock had a trading volume of 26,004,429 shares, compared to its average volume of 20,891,493. The business's 50 day moving average price is $10.75 and its 200-day moving average price is $9.98. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $19.48. The company has a market cap of $9.23 billion, a price-to-earnings ratio of -1.04, a PEG ratio of 1.31 and a beta of 0.67.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period in the previous year, the business earned $0.66 EPS. The firm's revenue for the quarter was up 7.6% on a year-over-year basis. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Walgreens Boots Alliance Company Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Recommended Stories
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
